Colfosceril is a surfactant used in the treatment of respiratory distress syndrome (RDS) in neonates. It works by reducing surface tension in the lungs, helping the lungs expand more easily and improving oxygenation. Colfosceril is commonly administered to premature infants who have insufficient surfactant production. Side effects are generally rare but may include temporary low oxygen levels and lung inflammation.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Colfosceril and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Colfosceril impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Colfosceril-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
